Compare INSM & NRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | INSM | NRG |
|---|---|---|
| Founded | 1988 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.2B | 28.9B |
| IPO Year | 2000 | 1997 |
| Metric | INSM | NRG |
|---|---|---|
| Price | $144.04 | $155.48 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 23 | 13 |
| Target Price | $188.73 | ★ $197.77 |
| AVG Volume (30 Days) | 2.2M | ★ 2.9M |
| Earning Date | 05-21-2026 | 05-27-2026 |
| Dividend Yield | N/A | ★ 1.23% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 4.01 |
| Revenue | N/A | ★ $30,713,000,000.00 |
| Revenue This Year | $168.46 | $17.73 |
| Revenue Next Year | $65.97 | $4.51 |
| P/E Ratio | ★ N/A | $38.65 |
| Revenue Growth | N/A | ★ 9.18 |
| 52 Week Low | $60.40 | $79.57 |
| 52 Week High | $212.75 | $189.96 |
| Indicator | INSM | NRG |
|---|---|---|
| Relative Strength Index (RSI) | 40.73 | 41.22 |
| Support Level | $139.81 | $144.04 |
| Resistance Level | $149.08 | $157.57 |
| Average True Range (ATR) | 6.51 | 7.22 |
| MACD | -0.41 | -2.98 |
| Stochastic Oscillator | 16.94 | 15.32 |
Insmed Inc is a biopharmaceutical company. Its commercial portfolio and clinical pipeline are organized around three therapeutic areas: Respiratory, Immunology and Inflammation, and Neuro and Other Rare. The company's two commercial products, Arikayce and Brinsupri, are both part of the Respiratory therapeutic area. The firm's clinical-stage programs are TPIP, INS1148, brensocatib, and INS1201, focusing on different therapeutic areas. Additionally, Insmed's pre-clinical research programs encompass various technologies and modalities, including gene therapy, AI-driven protein engineering, protein manufacturing, RNA end-joining, and synthetic rescue. Geographically, the company generates maximum revenue from the United States from the sale of its commercial products.
NRG Energy is one of the largest retail energy providers in the US, with 6 million customers. Vivint Smart Home, which NRG acquired in 2023, has 2 million home-services customers. NRG also is one of the largest US independent power producers, with 13 gigawatts of coal, gas, and oil power generation capacity primarily in Texas. The LS Power asset acquisition adds 13 GW of gas-fired power plants mostly in the Eastern US. NRG exited Chapter 11 bankruptcy as a stand-alone entity in December 2003.